Additionally, serum PTX3, an independent risk factor for HCC, may be used as a diagnostic marker, particularly for distinguishing early-stage HCC in hepatitis B virus (HBV)-infected patients, especially those who are AFP-negative (98). Here, PTX3 is linked to hepatocellular carcinoma.